More than ever, clinicians need to rely on a multimodal approach to pain management that includes behavioral therapy, nerve blocks, acupuncture, and more. Also today, canagliflozin’s HbA1c effect has been muted over time by the effects seen in the placebo group, most patients with COPD who are on triple therapy can withdraw from steroids, and specialty practices are hiring more physician assistants and nurse practitioners.
Listen to the MDedge Daily News podcast for all the details on today’s top news.
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.